AVR.US Anteris Technologies Global Corp. Common Stock

Healthcare Health Care Equipment & Supplies USA Stocks
5.42 USD
Close of Nov 14, 2026
3.30 11.06
Market cap
USD 528M
P/E
-
P/B
2.52x
ROE
-46.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is AVR.US undervalued?

Graham number

The Graham number of Anteris Technologies Global Corp. Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Anteris Technologies Global Corp. Common Stock fundamental analysis

No fundamental analysis for Anteris Technologies Global Corp. Common Stock yet.

Anteris Technologies Global Corp. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Anteris Technologies Global Corp. Common Stock

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenog…

Full company profile